Back to MW Marshall Wace, LLP

TNGXTNGX

Showing 8 of 13 quarters

Position history for MWMarshall Wace, LLP's holdings in Tango Therapeutics, Inc.

Yes. Marshall Wace holds 174,909 shares of TNGX (Tango Therapeutics), worth $5.5M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$5.5M

Current Shares

174,909

Total Value Change

+$4.9M

Total Shares Change

+101,787

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
174,909
—
$5.5M0.0%$31.26
37
2026-Q1
Exited
0
-100.0%
$00.0%$20.92
0
2025-Q4
Decreased
329,231
-77.9%
$2.9M0.0%$8.86
0
2025-Q3
Decreased
1.5M
-14.5%
$12.5M0.0%$8.40
0
2025-Q2
Decreased
1.7M
-5.4%
$8.9M0.0%$5.12
0
2025-Q1
New
1.8M
—
$2.5M0.0%$1.37
36
2024-Q4
Exited
0
-100.0%
$00.0%$3.09
0
2024-Q3
New
73,122
—
$563,0400.0%$7.47
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used